Chinese Biotech Firm Biotheus Raises $26M In A New Round

Login to View

Biotheus, a Chinese biotech firm, has raised RMB180 million (US$25.83 million) in a new funding round from a Zhuhai government-owned investment firm, Highlight Capital, a venture capital firm, and Zhuhai Huajin Asset Co. Ltd.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in

Join China Money Network for $89 a month



  1. This is journalist, author and global cancer patient advocate Jamie Reno. I would like to contact Biothus, there is very little information online about the company. Is there a website? A contact email? Many thanks. Jamie